BioCentury
ARTICLE | Financial News

Gracell raises $85M series B to advance cell therapies

February 25, 2019 9:39 PM UTC

Temasek led an $85 million series B round for cell therapy company Gracell Biotechnologies Co. Ltd. (Suzhou, China). Lilly Asia Ventures, Kington Capital, King Star Capital and Chengdu Miaoji also participated in the round.

Gracell, which was founded in 2017 and received backing in its series A round from 6 Dimensions, is developing CAR T cell products, including off-the-shelf products and therapies to treat refractory solid tumors...